ACT Brief: Moving Beyond AI Pilots, FDA Advances Bayesian Trials, and Sites Strained by Trial Design
In today’s ACT Brief, we examine what will separate sponsors that scale AI beyond pilots in 2026, break down the FDA’s new ...
The FDA’s new draft guidance on Bayesian methodology signals a shift toward more flexible, data-driven clinical trial designs, enabling sponsors to use prior data and adaptive approaches to improve ...
A problem of interest for ecology and conservation is that of determining the best allocation of survey effort in studies aimed at estimating the proportion of sites occupied by a species. Many ...
Evaluation of the HER/PI3K/AKT Family Signaling Network as a Predictive Biomarker of Pathologic Complete Response for Patients With Breast Cancer Treated With Neratinib in the I-SPY 2 TRIAL BaSyc is ...
WILMINGTON, N.C. & COLLEGE STATION, Texas--(BUSINESS WIRE)-- PPD, Inc. (Nasdaq: PPDI) and Berry Consultants, LLC today announced they have entered into a collaboration in the area of Bayesian ...
Quantum designers: Florian Marquardt (left) and Leopoldo Sarra have shown how deep Bayesian experimental design can be applied to quantum many-body systems. (Courtesy: Leopoldo Sarra) As quantum ...
Bayesian experimental design for a clinical trial involves specifying a utility function that models the purpose of the trial, in this case the selection of patients for a diagnostic test. The best ...
Bayesian Information Design and Mechanism Optimization is an interdisciplinary field that synthesises insights from economics, statistics, and game theory to address challenges of asymmetric ...
Researchers have employed Bayesian neural network approaches to evaluate the distributions of independent and cumulative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback